The trusted data and intuitive software your organization needs to get pay right.
Explore CompAnalyst ®Get direct access to executive and director pay data extracted from proxy filings and annual reports for all US public companies.
Explore CompAnalyst ExecutiveGet access to aggregate nationwide compensation data immediately, including Salary.com's largest, most comprehensive compensation dataset.
Get Benchmark Job ReportOrum Therapeutics is pioneering the development of tumor-directed targeted protein degraders to improve the treatment of cancer. The company's Antibody neoDegrader Conjugate (AnDC) platform enables first-in-class targeted protein degraders that are specific to cancer cells. The first therapeutic candidates from the AnDC platform are in development for the treatment of solid tumors and hematologic ...